Non-GAAP earnings per share of $0.29 in Q2 FY2025 beat expectations, but GAAP revenue missed estimates and GAAP net sales declined 4.0% from the prior year. Management lowered its FY2025 outlook, now ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $23.62, ...

Kenvue, facing investor pressure and lackluster performance in its skin health and beauty unit, has cut its annual sales ...

Recent health news highlights include Kenvue cutting its sales forecast amid strategic changes, Eli Lilly raising its profit ...